ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 324 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 1.86 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $5,930,000 | – | 128,000 | – | 1.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 16,459,128 | $234,543,000 | 9.43% |
APIS CAPITAL ADVISORS, LLC | 490,000 | $6,983,000 | 9.36% |
BVF INC/IL | 4,744,062 | $67,603,000 | 8.84% |
First Light Asset Management, LLC | 2,853,826 | $40,667,000 | 6.48% |
SECTORAL ASSET MANAGEMENT INC | 2,165,767 | $30,862,000 | 4.20% |
GREAT POINT PARTNERS LLC | 1,850,000 | $26,363,000 | 3.33% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 146,952 | $2,092,000 | 2.46% |
Birchview Capital, LP | 168,000 | $2,394,000 | 2.26% |
X-Square Capital, LLC | 180,554 | $2,572,000 | 2.02% |
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD | 295,610 | $4,212,000 | 1.54% |